RAC June 2025 Quarterly Activity Report and Appendix 4C 23/07/25 PRICE SENSITIVE download Created with Sketch. 540.07KB Share RAC RC220 Human Ethics Approvals Received in Hong Kong 10/07/25 PRICE SENSITIVE download Created with Sketch. 219.4KB Share RAC First Patient Safely Combine Dosed in Phase 1 RC220 Trial 19/06/25 PRICE SENSITIVE download Created with Sketch. 260.97KB Share RAC First Patient Dosed Safely in RC220 Phase 1 Trial 01/05/25 PRICE SENSITIVE download Created with Sketch. 199.65KB Share RAC March 2025 Quarterly Activity Report and Appendix 4C 23/04/25 PRICE SENSITIVE download Created with Sketch. 505.33KB Share RAC Enrolment Opened at Second Site for RC220 Phase 1 Trial 22/04/25 PRICE SENSITIVE download Created with Sketch. 267.59KB Share RAC RC220 Phase 1 Trial Opens for Patient Enrolment 03/04/25 PRICE SENSITIVE download Created with Sketch. 204.34KB Share RAC Race Initiates First AU Site for Phase 1 Solid Tumour Trial 27/03/25 PRICE SENSITIVE download Created with Sketch. 335.86KB Share RAC Ethics approval received for RC220 Phase 1 Trial 14/03/25 PRICE SENSITIVE download Created with Sketch. 215.07KB Share RAC S&P DJI Announces March 2025 Quarterly Rebalance 07/03/25 PRICE SENSITIVE download Created with Sketch. 174.42KB Share RAC Race Signs Contract for Phase 1 Trial of RC220 05/03/25 PRICE SENSITIVE download Created with Sketch. 245.66KB Share RAC Appendix 4D & Half-Year Financial Statements 25/02/25 PRICE SENSITIVE download Created with Sketch. 1.16MB Share RAC Quarterly Activity Report and Appendix 4C 31/01/25 PRICE SENSITIVE download Created with Sketch. 398.63KB Share RAC Race Receives $5.25m RD Tax Refund for Financial Year 2024 17/12/24 PRICE SENSITIVE download Created with Sketch. 239.36KB Share RAC Race Submits Human Ethics for RC220 Phase 1 Trial 05/12/24 PRICE SENSITIVE download Created with Sketch. 735.35KB Share RAC Race Discovers Multiple Novel FTO Inhibitor Candidates 21/11/24 PRICE SENSITIVE download Created with Sketch. 414.24KB Share RAC Quarterly Activity Report and Appendix 4C 21/10/24 PRICE SENSITIVE download Created with Sketch. 1023.42KB Share RAC Race Oncology Board Renewal Update 02/09/24 PRICE SENSITIVE download Created with Sketch. 803.33KB Share RAC Appendix 4E & Annual Report 27/08/24 PRICE SENSITIVE download Created with Sketch. 4.29MB Share RAC Bisantrene Phase 2 AML Trial Successful Concludes 30/07/24 PRICE SENSITIVE download Created with Sketch. 755KB Share RAC Quarterly Activity Report and Appendix 4C 23/07/24 PRICE SENSITIVE download Created with Sketch. 999.83KB Share RAC RC220 GLP Non-clinical Toxicology Program Successful 26/06/24 PRICE SENSITIVE download Created with Sketch. 743.84KB Share RAC Race Appoints George Clinical for Phase 1 Trial of RC220 20/06/24 PRICE SENSITIVE download Created with Sketch. 743.82KB Share RAC FDA RPD Designation Granted for RC220 Bisantrene 18/06/24 PRICE SENSITIVE download Created with Sketch. 767.82KB Share RAC Bisantrene Highly Active in a Multiple Myeloma Mouse Model 13/06/24 PRICE SENSITIVE download Created with Sketch. 651.5KB Share RAC US FDA Orphan Drug Designation Awarded to RC220 Bisantrene 11/06/24 PRICE SENSITIVE download Created with Sketch. 348.02KB Share RAC Bisantrene with Decitabine Enhances Cancer Cell Killing 14/05/24 PRICE SENSITIVE download Created with Sketch. 1.37MB Share RAC Quarterly Activity Report & Appendix 4C 18/04/24 PRICE SENSITIVE download Created with Sketch. 479.94KB Share RAC RC220 cGMP Manufacturing Complete 26/03/24 PRICE SENSITIVE download Created with Sketch. 315.62KB Share RAC Bisantrene shows potent anticancer activity in AML models 06/03/24 PRICE SENSITIVE download Created with Sketch. 856.44KB Share RAC S&P DJI Announces March 2024 Quarterly Rebalance 01/03/24 PRICE SENSITIVE download Created with Sketch. 120.24KB Share RAC Appendix 4D & Half-Year Financial Statements 28/02/24 PRICE SENSITIVE download Created with Sketch. 4.3MB Share RAC Race Receives $4.0m R&D Tax Refund for Financial Year 2023 27/02/24 PRICE SENSITIVE download Created with Sketch. 264.05KB Share RAC Quarterly Activity Report & Appendix 4C 30/01/24 PRICE SENSITIVE download Created with Sketch. 628.97KB Share RAC December 2023 Preclinical & Clinical Program Update 29/12/23 PRICE SENSITIVE download Created with Sketch. 352.32KB Share RAC Bonus Options Prospectus 22/11/23 PRICE SENSITIVE download Created with Sketch. 393.29KB Share RAC Updated Strategy and Investor Presentation 22/11/23 PRICE SENSITIVE download Created with Sketch. 2.05MB Share RAC Dr Daniel Tillett appointed CEO of Race Oncology 22/11/23 PRICE SENSITIVE download Created with Sketch. 302.46KB Share RAC RC220 Meets Quality Specifications 09/11/23 PRICE SENSITIVE download Created with Sketch. 327.14KB Share RAC Impressive Bisantrene Phase 2 AML Clinical Results 06/11/23 PRICE SENSITIVE download Created with Sketch. 937.9KB Share RAC Trading Halt 03/11/23 PRICE SENSITIVE download Created with Sketch. 349KB Share RAC Quarterly Activity Report & Appendix 4C 23/10/23 PRICE SENSITIVE download Created with Sketch. 483.58KB Share RAC RC220 Peripheral Infusion Safety Confirmed 17/10/23 PRICE SENSITIVE download Created with Sketch. 294.3KB Share RAC RC220 Toxicology and Safety Pharmacology Studies Initiated 05/10/23 PRICE SENSITIVE download Created with Sketch. 299.18KB Share RAC Bisantrene cGMP API Manufacturing Completed at Laurus Labs 27/09/23 PRICE SENSITIVE download Created with Sketch. 301.44KB Share RAC Bisantrene Shows Broad Anti-Cancer Activity in Cancer Cells 21/09/23 PRICE SENSITIVE download Created with Sketch. 322.24KB Share RAC Appendix 4E & Annual Report 30/08/23 PRICE SENSITIVE download Created with Sketch. 1.73MB Share RAC Race Board and Management Team Changes 22/08/23 PRICE SENSITIVE download Created with Sketch. 303.9KB Share RAC Race Strategic Update August 2023 08/08/23 PRICE SENSITIVE download Created with Sketch. 5.62MB Share RAC Quarterly Activity Report & Appendix 4C 31/07/23 PRICE SENSITIVE download Created with Sketch. 325.58KB Share RAC Race Receives Additional $1.66m R&D Tax Refund for FY 2022 13/07/23 PRICE SENSITIVE download Created with Sketch. 98.17KB Share RAC Race executes agreement with Ardena for GMP manufacturing 12/07/23 PRICE SENSITIVE download Created with Sketch. 103.46KB Share RAC Race global agreement with City of Hope to access FTO IP 10/07/23 PRICE SENSITIVE download Created with Sketch. 136.17KB Share RAC H1 2023 Preclinical and Clinical Programs Update 07/07/23 PRICE SENSITIVE download Created with Sketch. 186.32KB Share RAC Letter to Shareholders 15/06/23 PRICE SENSITIVE download Created with Sketch. 96.85KB Share RAC Quarterly Activity Report & Appendix 4C 28/04/23 PRICE SENSITIVE download Created with Sketch. 423.96KB Share RAC Race releases complete cardio-protection data & video 14/04/23 PRICE SENSITIVE download Created with Sketch. 3.13MB Share RAC Race releases cardioprotection market potential data 04/04/23 PRICE SENSITIVE download Created with Sketch. 615.57KB Share RAC Race Receives $1.48m R&D Tax Refund for Financial Year 2022 27/03/23 PRICE SENSITIVE download Created with Sketch. 81.67KB Share RAC Race Leadership Changes 24/03/23 PRICE SENSITIVE download Created with Sketch. 107.25KB Share RAC Trading Halt 22/03/23 PRICE SENSITIVE download Created with Sketch. 217.33KB Share RAC Pause in Trading 22/03/23 PRICE SENSITIVE download Created with Sketch. 115.29KB Share RAC Race Executes Contracts to Commence Breast Cancer Trial 13/03/23 PRICE SENSITIVE download Created with Sketch. 128.41KB Share RAC New Collaboration to Understand Zantrene Cardioprotection 02/03/23 PRICE SENSITIVE download Created with Sketch. 110.53KB Share RAC Appendix 4D & Half-Year Financial Statements 27/02/23 PRICE SENSITIVE download Created with Sketch. 745.76KB Share RAC Race Receives Cardioprotection Ethics Trial Approval 01/02/23 PRICE SENSITIVE download Created with Sketch. 126.08KB Share RAC Quarterly Activity Report & Appendix 4C 31/01/23 PRICE SENSITIVE download Created with Sketch. 335.85KB Share RAC Race supports Study of Extramedullary AML 22/12/22 PRICE SENSITIVE download Created with Sketch. 167.5KB Share RAC Race Appoints Damian Clarke-Bruce as CEO & Managing Director 14/12/22 PRICE SENSITIVE download Created with Sketch. 127.41KB Share RAC Positive Pre-IND Guidance from FDA on Zantrene 23/11/22 PRICE SENSITIVE download Created with Sketch. 101.59KB Share RAC Quarterly Activity Report & Appendix 4C 27/10/22 PRICE SENSITIVE download Created with Sketch. 377.64KB Share RAC Response to ASX Price Query 18/10/22 PRICE SENSITIVE download Created with Sketch. 248.77KB Share RAC Race Develops Improved IV Formulation of Zantrene 28/09/22 PRICE SENSITIVE download Created with Sketch. 124.87KB Share RAC Race Initiates New Drug Discovery Program 27/09/22 PRICE SENSITIVE download Created with Sketch. 111.39KB Share RAC Appendix 4E & Annual Report 26/08/22 PRICE SENSITIVE download Created with Sketch. 1.75MB Share RAC Quarterly Activity Report & Appendix 4C 22/07/22 PRICE SENSITIVE download Created with Sketch. 382.73KB Share RAC Zantrene Protects Mouse Hearts from Chemotherapy Damage 30/06/22 PRICE SENSITIVE download Created with Sketch. 1.4MB Share RAC Zantrene shows synergy with kinase inhibitors in melanoma 28/06/22 PRICE SENSITIVE download Created with Sketch. 1.79MB Share RAC Zantrene Improves Immune Therapy Treatment of Melanoma 22/06/22 PRICE SENSITIVE download Created with Sketch. 1014.98KB Share RAC Race Oncology Announces On-Market Share Buyback 09/06/22 PRICE SENSITIVE download Created with Sketch. 91.49KB Share RAC EMD AML MDS Trial Expands to Europe 08/06/22 PRICE SENSITIVE download Created with Sketch. 362.22KB Share RAC Zantrene AML trial in Israel advances to Phase 2 27/05/22 PRICE SENSITIVE download Created with Sketch. 196.95KB Share RAC Trading Halt 26/05/22 PRICE SENSITIVE download Created with Sketch. 545.91KB Share RAC Pause in Trading 26/05/22 PRICE SENSITIVE download Created with Sketch. 115.78KB Share RAC Race Receives Governance Approval for AML EMD & MDS Trial 12/05/22 PRICE SENSITIVE download Created with Sketch. 158.97KB Share RAC Quarterly Activity Report & Appendix 4C 21/04/22 PRICE SENSITIVE download Created with Sketch. 383.15KB Share RAC Race receives Human Ethics AML Trial Approval 06/04/22 PRICE SENSITIVE download Created with Sketch. 174.68KB Share RAC Supply Agreement for EMD AML Trial 30/03/22 PRICE SENSITIVE download Created with Sketch. 111.72KB Share RAC Zantrene highly effective in EMD AML Mouse Model 17/03/22 PRICE SENSITIVE download Created with Sketch. 1.42MB Share RAC Compelling Zantrene Preclinical Kidney Cancer Data 10/03/22 PRICE SENSITIVE download Created with Sketch. 1.79MB Share RAC Appendix 4D & Half-Year Financial Statements 25/02/22 PRICE SENSITIVE download Created with Sketch. 908.64KB Share RAC MD Anderson Preclinical AML Study on Zantrene Published 23/02/22 PRICE SENSITIVE download Created with Sketch. 97.94KB Share RAC Quarterly Activity Report & Appendix 4C 28/01/22 PRICE SENSITIVE download Created with Sketch. 597.56KB Share RAC Race raises $29.7 million in oversubscribed SPP 21/12/21 PRICE SENSITIVE download Created with Sketch. 102.65KB Share RAC Expanded Heart Protection Discovery for Zantrene 08/12/21 PRICE SENSITIVE download Created with Sketch. 478.7KB Share RAC Race Oncology Investor Presentation - November 2021 23/11/21 PRICE SENSITIVE download Created with Sketch. 9.02MB Share RAC Race Oncology Share Purchase Plan 23/11/21 PRICE SENSITIVE download Created with Sketch. 83.88KB Share RAC AGM Presentations 23/11/21 PRICE SENSITIVE download Created with Sketch. 3.19MB Share RAC Trading Halt 23/11/21 PRICE SENSITIVE download Created with Sketch. 225.88KB Share RAC Breakthrough Zantrene Heart Protection Discovery 22/11/21 PRICE SENSITIVE download Created with Sketch. 1.24MB Share
(20min delay)
